Keywords: fda, extends, decision, date, requip, xl, 2nd-qtr

FDA extends decision date on Requip XL to 2nd-qtr 2008

Article | 11 February 2008

Print This

GlaxoSmithKline and fellow UK-based SkyePharma say that the US Food and Drug Administration has extended its decision date regarding the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in